Annual ROE
-49.74%
-15.95%-47.20%
30 September 2023
Summary:
Enanta Pharmaceuticals annual return on equity is currently -49.74%, with the most recent change of -15.95% (-47.20%) on 30 September 2023. During the last 3 years, it has fallen by -31.26% (-169.16%). ENTA annual ROE is now -146.84% below its all-time high of 106.18%, reached on 30 September 2011.ENTA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-59.98%
+0.90%+1.48%
30 June 2024
Summary:
Enanta Pharmaceuticals quarterly return on equity is currently -59.98%, with the most recent change of +0.90% (+1.48%) on 30 June 2024. Over the past year, it has dropped by -10.27% (-20.66%). ENTA quarterly ROE is now -107.04% below its all-time high of 851.57%, reached on 31 December 2012.ENTA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -20.7% |
| 3 y3 years | -169.2% | -228.1% |
| 5 y5 years | -558.9% | -660.6% |
ENTA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -169.2% | at low | -228.1% | +1.5% |
| 5 y | 5 years | -558.9% | at low | -660.6% | +1.5% |
| alltime | all time | -146.8% | at low | -107.0% | +7.0% |
Enanta Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -59.98%(-1.5%) |
| Mar 2024 | - | -60.88%(+7.2%) |
| Dec 2023 | - | -56.81%(+14.3%) |
| Sept 2023 | -49.74%(+47.2%) | -49.71%(+10.5%) |
| June 2023 | - | -45.00%(+14.6%) |
| Mar 2023 | - | -39.26%(+10.9%) |
| Dec 2022 | - | -35.41%(+4.8%) |
| Sept 2022 | -33.79%(+82.8%) | -33.79%(+6.9%) |
| June 2022 | - | -31.61%(+12.4%) |
| Mar 2022 | - | -28.13%(+16.7%) |
| Dec 2021 | - | -24.11%(+31.9%) |
| Sept 2021 | -18.48%(+134.5%) | -18.28%(-2.1%) |
| June 2021 | - | -18.67%(+16.6%) |
| Mar 2021 | - | -16.01%(+30.3%) |
| Dec 2020 | - | -12.29%(+60.9%) |
| Sept 2020 | -7.88%(-172.7%) | -7.64%(-1628.0%) |
| June 2020 | - | 0.50%(-90.2%) |
| Mar 2020 | - | 5.11%(-31.8%) |
| Dec 2019 | - | 7.49%(-30.0%) |
| Sept 2019 | 10.84%(-47.6%) | 10.70%(-31.6%) |
| June 2019 | - | 15.64%(-21.6%) |
| Mar 2019 | - | 19.95%(-15.3%) |
| Dec 2018 | - | 23.54%(+11.7%) |
| Sept 2018 | 20.70% | 21.07%(-18.1%) |
| June 2018 | - | 25.74%(+45.6%) |
| Mar 2018 | - | 17.68%(+45.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | - | 12.16%(+87.7%) |
| Sept 2017 | 6.20%(-27.6%) | 6.48%(-183.9%) |
| June 2017 | - | -7.72%(+56.0%) |
| Mar 2017 | - | -4.95%(+39.4%) |
| Dec 2016 | - | -3.55%(-142.8%) |
| Sept 2016 | 8.56%(-79.2%) | 8.30%(-28.3%) |
| June 2016 | - | 11.58%(-13.8%) |
| Mar 2016 | - | 13.44%(-51.2%) |
| Dec 2015 | - | 27.55%(-28.1%) |
| Sept 2015 | 41.06%(+54.5%) | 38.31%(+6.6%) |
| June 2015 | - | 35.94%(-49.0%) |
| Mar 2015 | - | 70.49%(+21.1%) |
| Dec 2014 | - | 58.22%(+109.4%) |
| Sept 2014 | 26.58%(+113.2%) | 27.80%(-7.1%) |
| June 2014 | - | 29.94%(-272.1%) |
| Mar 2014 | - | -17.40%(+1.3%) |
| Dec 2013 | - | -17.18%(-261.8%) |
| Sept 2013 | 12.47%(-80.8%) | 10.62%(-50.7%) |
| June 2013 | - | 21.53%(-43.3%) |
| Mar 2013 | - | 37.99%(-95.5%) |
| Dec 2012 | - | 851.57%(-1419.6%) |
| Sept 2012 | 64.96%(-38.8%) | -64.53%(+32.8%) |
| June 2012 | - | -48.61%(-142.7%) |
| Mar 2012 | - | 113.71%(-449.2%) |
| Dec 2011 | - | -32.56%(+79.2%) |
| Sept 2011 | 106.18% | -18.17% |
FAQ
- What is Enanta Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly ROE year-on-year change?
What is Enanta Pharmaceuticals annual return on equity?
The current annual ROE of ENTA is -49.74%
What is the all time high annual ROE for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual return on equity is 106.18%
What is Enanta Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ENTA is -59.98%
What is the all time high quarterly ROE for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly return on equity is 851.57%
What is Enanta Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ENTA quarterly return on equity has changed by -10.27% (-20.66%)